US Stock MarketDetailed Quotes

PLRX Pliant Therapeutics

Watchlist
  • 1.450
  • -0.030-2.03%
Trading Apr 30 11:07 ET
89.01MMarket Cap-0.42P/E (TTM)

Pliant Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
-83.69%1.58M
0
0
-95.03%248K
6.65%1.33M
Operating revenue
--0
--0
--0
--0
--0
-83.69%1.58M
--0
--0
-95.03%248K
6.65%1.33M
Cost of revenue
Gross profit
Operating expense
22.96%228.37M
13.36%53.32M
30.05%62.01M
27.46%60.64M
20.64%52.39M
35.68%185.73M
19.49%47.04M
42.65%47.69M
37.38%47.58M
47.41%43.43M
Selling and administrative expenses
1.95%59.06M
4.86%14.53M
-7.08%14.26M
3.07%15.02M
7.72%15.25M
45.00%57.93M
-2.79%13.85M
73.93%15.35M
75.68%14.57M
64.98%14.15M
-General and administrative expense
1.95%59.06M
4.86%14.53M
-7.08%14.26M
3.07%15.02M
7.72%15.25M
45.00%57.93M
-2.79%13.85M
73.93%15.35M
75.68%14.57M
64.98%14.15M
Research and development costs
32.48%169.31M
16.91%38.79M
47.67%47.75M
38.22%45.62M
26.90%37.15M
31.84%127.8M
32.13%33.18M
31.43%32.34M
25.32%33M
40.19%29.27M
Operating profit
-24.01%-228.37M
-13.36%-53.32M
-30.05%-62.01M
-28.13%-60.64M
-24.46%-52.39M
-44.77%-184.15M
-25.77%-47.04M
-49.26%-47.69M
-59.67%-47.33M
-49.21%-42.1M
Net non-operating interest income expense
-20.82%18.06M
-39.47%3.59M
-31.41%4.25M
-22.02%4.79M
19.57%5.44M
488.01%22.81M
153.33%5.93M
365.32%6.2M
6,291.67%6.14M
3,996.40%4.55M
Non-operating interest income
-12.42%21.09M
-29.24%4.42M
-21.29%5.13M
-12.42%5.65M
21.08%5.88M
415.55%24.08M
135.19%6.25M
298.96%6.52M
2,299.63%6.46M
4,276.58%4.86M
Non-operating interest expense
138.67%3.02M
159.81%834K
176.66%877K
172.10%868K
43.09%445K
60.18%1.27M
1.26%321K
5.32%317K
84.39%319K
--311K
Other net income (expense)
Income before tax
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
Income tax
Net income
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
Net income continuous Operations
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
Minority interest income
Net income attributable to the parent company
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
-35.51%-41.49M
-39.42%-41.19M
-33.62%-37.55M
Basic earnings per share
-26.18%-3.47
-18.84%-0.82
-35.71%-0.95
-31.43%-0.92
-16.42%-0.78
6.46%-2.75
4.17%-0.69
-7.69%-0.7
14.63%-0.7
14.10%-0.67
Diluted earnings per share
-26.18%-3.47
-18.84%-0.82
-35.71%-0.95
-31.43%-0.92
-16.42%-0.78
6.46%-2.75
4.17%-0.69
-7.69%-0.7
14.63%-0.7
14.10%-0.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 00000-83.69%1.58M00-95.03%248K6.65%1.33M
Operating revenue --0--0--0--0--0-83.69%1.58M--0--0-95.03%248K6.65%1.33M
Cost of revenue
Gross profit
Operating expense 22.96%228.37M13.36%53.32M30.05%62.01M27.46%60.64M20.64%52.39M35.68%185.73M19.49%47.04M42.65%47.69M37.38%47.58M47.41%43.43M
Selling and administrative expenses 1.95%59.06M4.86%14.53M-7.08%14.26M3.07%15.02M7.72%15.25M45.00%57.93M-2.79%13.85M73.93%15.35M75.68%14.57M64.98%14.15M
-General and administrative expense 1.95%59.06M4.86%14.53M-7.08%14.26M3.07%15.02M7.72%15.25M45.00%57.93M-2.79%13.85M73.93%15.35M75.68%14.57M64.98%14.15M
Research and development costs 32.48%169.31M16.91%38.79M47.67%47.75M38.22%45.62M26.90%37.15M31.84%127.8M32.13%33.18M31.43%32.34M25.32%33M40.19%29.27M
Operating profit -24.01%-228.37M-13.36%-53.32M-30.05%-62.01M-28.13%-60.64M-24.46%-52.39M-44.77%-184.15M-25.77%-47.04M-49.26%-47.69M-59.67%-47.33M-49.21%-42.1M
Net non-operating interest income expense -20.82%18.06M-39.47%3.59M-31.41%4.25M-22.02%4.79M19.57%5.44M488.01%22.81M153.33%5.93M365.32%6.2M6,291.67%6.14M3,996.40%4.55M
Non-operating interest income -12.42%21.09M-29.24%4.42M-21.29%5.13M-12.42%5.65M21.08%5.88M415.55%24.08M135.19%6.25M298.96%6.52M2,299.63%6.46M4,276.58%4.86M
Non-operating interest expense 138.67%3.02M159.81%834K176.66%877K172.10%868K43.09%445K60.18%1.27M1.26%321K5.32%317K84.39%319K--311K
Other net income (expense)
Income before tax -30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M
Income tax
Net income -30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M
Net income continuous Operations -30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M
Minority interest income
Net income attributable to the parent company -30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M-35.51%-41.49M-39.42%-41.19M-33.62%-37.55M
Basic earnings per share -26.18%-3.47-18.84%-0.82-35.71%-0.95-31.43%-0.92-16.42%-0.786.46%-2.754.17%-0.69-7.69%-0.714.63%-0.714.10%-0.67
Diluted earnings per share -26.18%-3.47-18.84%-0.82-35.71%-0.95-31.43%-0.92-16.42%-0.786.46%-2.754.17%-0.69-7.69%-0.714.63%-0.714.10%-0.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More